Dr. Martens (LON:DOCS) Trading Up 7.2% – What’s Next?

Dr. Martens plc (LON:DOCS)’s share price was up 7.2% during mid-day trading on Tuesday . The stock traded as high as GBX 71.30 and last traded at GBX 68.90. Approximately 1,553,801 shares traded hands during trading, a decline of 84% from the average daily volume of 9,968,290 shares. The stock had previously closed at GBX 64.30.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on DOCS shares. Berenberg Bank reiterated a “buy” rating and set a GBX 114 price objective on shares of Dr. Martens in a research note on Wednesday, May 6th. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Dr. Martens in a research note on Tuesday, February 3rd. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Dr. Martens has an average rating of “Moderate Buy” and a consensus target price of GBX 114.

Dr. Martens Stock Performance

The company has a market capitalization of £672.59 million, a price-to-earnings ratio of 40.91, a price-to-earnings-growth ratio of 6.40 and a beta of 0.22. The company has a debt-to-equity ratio of 120.66, a current ratio of 2.18 and a quick ratio of 1.13. The stock has a 50 day moving average price of GBX 63.94 and a two-hundred day moving average price of GBX 71.49.

Insider Buying and Selling at Dr. Martens

In other news, insider Ije Nwokori sold 204,051 shares of the firm’s stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of GBX 66, for a total value of £134,673.66. Insiders acquired 930 shares of company stock valued at $59,984 in the last three months. Company insiders own 2.81% of the company’s stock.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.